data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

electroCore

(NASDAQ:ECOR)

Intraday

$6.01

0.39[6.94%]

15 minutes delayed

Perks Buy Compare Brokers

$6.01

0.39[6.94%]

Last update: 8:40AM Get Real Time Here

Overview News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest News for electroCore Stock (NASDAQ:ECOR)

electroCore Stock (NASDAQ: ECOR)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, April 08, 2024

electroCore Launches Truvaga Plus For General Wellness
Benzinga Newsdesk - Apr 8, 2024, 8:44AM

Tuesday, April 02, 2024

electroCore Expands Intellectual Property Portfolio With Two New Patents, "No. 11,944,815" And "No. 11,944,807"
Benzinga Newsdesk - Apr 2, 2024, 8:18AM

Thursday, March 14, 2024

HC Wainwright & Co. Reiterates Buy on electroCore, Maintains $15 Price Target
Benzinga Newsdesk - Mar 14, 2024, 6:52AM

Wednesday, March 13, 2024

electroCore Q4 2023 GAAP EPS $(0.61), Inline, Sales $5.191M Beat $4.967M Estimate
Benzinga Newsdesk - Mar 13, 2024, 4:07PM
Earnings Scheduled For March 13, 2024
Benzinga Insights - Mar 13, 2024, 6:15AM

Tuesday, March 12, 2024

A Preview Of electroCore's Earnings
Benzinga Insights - Mar 12, 2024, 1:01PM

Tuesday, February 06, 2024

electroCore Expands Intellectual Property Portfolio With U.S. Patent No. 11,894,148 entitled "Systems And Methods For Treating Patients With Diseases Associated With Viruses"
Benzinga Newsdesk - Feb 6, 2024, 8:11AM

Monday, January 22, 2024

HC Wainwright & Co. Maintains Buy on electroCore, Raises Price Target to $15
Benzinga Newsdesk - Jan 22, 2024, 7:33AM

Tuesday, January 09, 2024

electroCore Expands Intellectual Property Portfolio; Trademark Office Has Issued A Patent Related To Systems And Methods For Treating Post-traumatic Stress Disorder
Benzinga Newsdesk - Jan 9, 2024, 8:10AM

Tuesday, December 26, 2023

electroCore Expands Intellectual Property Portfolio; The Two Patents Were Issued On December 26, 2023, And Relate To ElectroCore's Non-Invasive Vagus Nerve Stimulation Technology
Happy Mohamed - Dec 26, 2023, 8:04AM

Tuesday, December 12, 2023

electroCore, Announced The U.S. Patent And Trademark Office Has Issued A Patent Related To A System For Stimulating A Nerve Target In The Head Or Neck Of A Patient For Treatment Of Various Disorders, Such As Primary Headache
Benzinga Newsdesk - Dec 12, 2023, 8:06AM

Thursday, November 09, 2023

HC Wainwright & Co. Maintains Buy on electroCore, Raises Price Target to $11
Benzinga Newsdesk - Nov 9, 2023, 7:24AM

Wednesday, November 08, 2023

ElectroCore Sees FY23 Revenue $15M-$15.5M Vs $14.43M Est.
Benzinga Newsdesk - Nov 8, 2023, 6:07PM
electroCore Q3 EPS $(0.68) Up From $(1.20) YoY, Sales $4.51M Up From $1.98M YoY
Benzinga Newsdesk - Nov 8, 2023, 4:44PM
Earnings Scheduled For November 8, 2023
Benzinga Insights - Nov 8, 2023, 4:21AM

Tuesday, October 17, 2023

ElectroCore's GammaCore Therapy Will Continue To Be Listed In The U.K's National Health Service Supply Chain Catalogue For Additional Two Years Till March 17, 2026. The Listing Commenced On June 4, 2019, Was Scheduled To Terminate On March 18, 2024
Benzinga Newsdesk - Oct 17, 2023, 8:03AM

Tuesday, October 10, 2023

electroCore, Inc. Announces Data Highlighting Non-Invasive Vagus Nerve Stimulation For Treatment Of Acute Neurological Injury Presented At 2023 World Stroke Congress
Benzinga Newsdesk - Oct 10, 2023, 8:03AM

Tuesday, September 05, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Sep 5, 2023, 9:06AM

Friday, August 11, 2023

Watching electroCore; Zacks Small-Cap Research Sets $29 Price Valuation; Says Our Valuation Is Generated Using A 20x Multiple Of 2027 Earnings And Discounting That Value To The Present Year At A 20% Rate
Happy Mohamed - Aug 11, 2023, 10:09AM

Thursday, August 10, 2023

HC Wainwright & Co. Reiterates Buy on electroCore, Maintains $10 Price Target
Benzinga Newsdesk - Aug 10, 2023, 6:45AM

Wednesday, August 09, 2023

electroCore Reiterates Its Revenue Guidance Of $14M-$15M For Calendar Year 2023; Consensus $14.24M
Benzinga Newsdesk - Aug 9, 2023, 5:41PM
electroCore Q2 EPS $(1.03) Misses $(1.00) Estimate, Sales $3.55M Beat $3.55M Estimate
Benzinga Newsdesk - Aug 9, 2023, 5:00PM
Earnings Scheduled For August 9, 2023
Benzinga Insights - Aug 9, 2023, 4:54AM

Tuesday, August 08, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Aug 8, 2023, 1:31PM
electroCore Director Awarded $143K Worth of Stock Options
Benzinga Insights - Aug 8, 2023, 11:00AM
Director at electroCore Acquires Company Stock Options Worth 36,383 Shares
Benzinga Insights - Aug 8, 2023, 11:00AM

Friday, August 04, 2023

Director of electroCore Makes $198K Buy
Benzinga Insights - Aug 4, 2023, 11:07AM
electroCore Director Trades $147K In Company Stock
Benzinga Insights - Aug 4, 2023, 11:07AM
DBV Technologies And 3 Other Penny Stocks Insiders Are Buying
Lisa Levin - Aug 4, 2023, 3:56AM

Thursday, August 03, 2023

electroCore Chief Financial Officer Awarded $87K Worth of Stock Options
Benzinga Insights - Aug 3, 2023, 11:00AM

Monday, July 31, 2023

ElectroCore, Inc. Announces $8.145M Registered Direct Offering And Concurrent Private Placements Priced At Market Under Nasdaq Rules
Happy Mohamed - Jul 31, 2023, 9:30AM

Thursday, July 27, 2023

12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights - Jul 27, 2023, 5:32PM

Tuesday, July 25, 2023

Electrocore Announced The Publication Of A Peer-reviewed Manuscript Regarding Gammacore (Non-Invasive Vagus Nerve Stimulation), Demonstrating Improved Attention And Memory In Patients With Posttraumatic Stress Disorder
Benzinga Newsdesk - Jul 25, 2023, 8:09AM

Tuesday, July 18, 2023

electroCore Expands Intellectual Patent Portfolio For nVNS Technology
Benzinga Newsdesk - Jul 18, 2023, 8:15AM

Thursday, July 13, 2023

electroCore, Inc. Announces Distribution Agreement With Reliefband Technologies, LLC
Happy Mohamed - Jul 13, 2023, 8:13AM

Thursday, July 06, 2023

NFL-Funded Study: CBD Or Non-Invasive Vagal Nerve Stimulation - Which Is Better To Alleviate Concussion Symptoms
Vuk Zdinjak - Jul 6, 2023, 10:21AM

Tuesday, June 20, 2023

ElectroCore Granted U.S. Patent #: 11679258: Stimulator for use with a mobile device
Charles Gross - Jun 20, 2023, 9:06AM

Thursday, May 11, 2023

electroCore Earnings Perspective: Return On Capital Employed
Benzinga Insights - May 11, 2023, 10:52AM

Thursday, May 04, 2023

Zacks Small-Cap Research Publishes Note On electroCore With $30 Valuation
Benzinga Newsdesk - May 4, 2023, 10:02AM
HC Wainwright & Co. Maintains Buy on electroCore, Raises Price Target to $10
Benzinga Newsdesk - May 4, 2023, 6:58AM

Wednesday, May 03, 2023

electroCore: Q1 Earnings Insights
Benzinga Insights - May 3, 2023, 4:05PM
electroCore Q1 EPS $(1.24) Misses $(1.00) Estimate, Sales $2.78M Miss $2.95M Estimate
Benzinga Newsdesk - May 3, 2023, 4:04PM

Wednesday, April 26, 2023

National Institutes Of Health Awards 3-year, $6M Grant For Pivotal Clinical Trial Of gammaCore In Patients With Opioid Use Disorders
Happy Mohamed - Apr 26, 2023, 8:24AM

Tuesday, April 18, 2023

HC Wainwright & Co. Maintains Buy on electroCore, Raises Price Target to $8
Benzinga Newsdesk - Apr 18, 2023, 6:17AM

Monday, April 17, 2023

electroCore Sees Prelim. Q1 Revenue $2.8M, Up 46% YoY
Benzinga Newsdesk - Apr 17, 2023, 8:19AM

Tuesday, April 11, 2023

ElectroCore Announces Remittance Of Annual License Fee From Teijin For Certain Exclusive Rights In Japan
Happy Mohamed - Apr 11, 2023, 8:12AM

Thursday, April 06, 2023

electroCore, Inc. Announces License To Import, Distribute And Market gammaCore Sapphire In Indonesia, Malaysia And South Africa
Benzinga Newsdesk - Apr 6, 2023, 8:03AM

Friday, March 24, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Mar 24, 2023, 1:30PM

Thursday, March 16, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Mar 16, 2023, 9:06AM

Friday, March 10, 2023

electroCore Earnings Perspective: Return On Capital Employed
Benzinga Insights - Mar 10, 2023, 9:50AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved